Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Bucher

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 21, 2025
A Complementarity-Based Approach to De Novo Binder DesignKateryna Maksymenko, Valeriia Hatskovska, Murray Coles, et al.
Blood|April 20, 2021
Dimethyl fumarate induces ferroptosis and impairs NF-κB/STAT3 signaling in DLBCLAnja Schmitt, Wendan Xu, Philip Bucher, et al.
Nature Communications|October 27, 2022
The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinomaJens Bauer, Natalie Köhler, Yacine Maringer, et al.
Nature Cancer|January 6, 2026
CAR-adapted PIK3CD base editing enhances T cell anti-tumor potencyPhilip Bucher, Nadine Brückner, Jule Kortendieck, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 21, 2025
A Complementarity-Based Approach to De Novo Binder DesignKateryna Maksymenko, Valeriia Hatskovska, Murray Coles, et al.
Blood|April 20, 2021
Dimethyl fumarate induces ferroptosis and impairs NF-κB/STAT3 signaling in DLBCLAnja Schmitt, Wendan Xu, Philip Bucher, et al.
Nature Communications|October 27, 2022
The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinomaJens Bauer, Natalie Köhler, Yacine Maringer, et al.
Nature Cancer|January 6, 2026
CAR-adapted PIK3CD base editing enhances T cell anti-tumor potencyPhilip Bucher, Nadine Brückner, Jule Kortendieck, et al.
Pageof 2